Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (201-210 of 245) with videos related to

Pageof 25
Sort By:
Medical and Pediatric Oncology|January 1, 1979
Thirty-six-hour preoperative high-dose methotrexate infusion in patients with squamous carcinoma of the head and neckK R Hande, P B Chretien, E G Elias, et al.
Seminars in Oncology|December 1, 1988
Reimbursement issues in clinical oncologyN J Vogelzang, B A Chabner, P Periman, et al.
Cancer Chemotherapy Reports|September 1, 1973
High-dose intermittent intravenous infusion of procarbazine (NSC-77213)B A Chabner, R Sponzo, S Hubbard, et al.
Proceedings. National Cancer Conference|January 1, 1972
Proceedings: Malignant lymphoma: treatment with combination chemotherapyV T De Vita, G P Canellos, P J Schein, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Seminars in Oncology|April 1, 1988
Treatment of Pneumocystis carinii pneumonia with trimetrexate in acquired immunodeficiency syndrome (AIDS)C J Allegra, B A Chabner, C U Tuazon, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.
The Oncologist|June 26, 2001
Losing GodR T Penson, R Z Yusuf, B A Chabner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
AntimetabolitesE Chu, P G Johnston, J L Grem, et al.
Pageof 25

Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
Medical and Pediatric Oncology|January 1, 1979
Thirty-six-hour preoperative high-dose methotrexate infusion in patients with squamous carcinoma of the head and neckK R Hande, P B Chretien, E G Elias, et al.
Seminars in Oncology|December 1, 1988
Reimbursement issues in clinical oncologyN J Vogelzang, B A Chabner, P Periman, et al.
Cancer Chemotherapy Reports|September 1, 1973
High-dose intermittent intravenous infusion of procarbazine (NSC-77213)B A Chabner, R Sponzo, S Hubbard, et al.
Proceedings. National Cancer Conference|January 1, 1972
Proceedings: Malignant lymphoma: treatment with combination chemotherapyV T De Vita, G P Canellos, P J Schein, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Seminars in Oncology|April 1, 1988
Treatment of Pneumocystis carinii pneumonia with trimetrexate in acquired immunodeficiency syndrome (AIDS)C J Allegra, B A Chabner, C U Tuazon, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolateJ A Kovacs, C J Allegra, J C Swan, et al.
The Oncologist|June 26, 2001
Losing GodR T Penson, R Z Yusuf, B A Chabner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
AntimetabolitesE Chu, P G Johnston, J L Grem, et al.
Pageof 25